Tri-coc 300 mg/g Proszek do sporządzania roztworu doustnego
Tri-coc 300 mg/g Proszek do sporządzania roztworu doustnego
Authorised
- Sulfaclozine sodium monohydrate
Product identification
Medicine name:
Tri-coc 300 mg/g Proszek do sporządzania roztworu doustnego
Active substance:
- Sulfaclozine sodium monohydrate
Target species:
-
Chicken (hen)
-
Rabbit
-
Turkey
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Sulfaclozine sodium monohydrate300.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken (hen)
-
Meat and offal16day
-
-
Rabbit
-
Meat and offal15day
-
-
Turkey
-
Meat and offal28day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51AG04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vet Planet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- PF Vetos Farma Sp. z o.o.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2301
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 5/06/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 5/06/2025